- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00772707
A Multi-Center Investigation of Patient Acceptability of OPTI-FREE RepleniSH® Multi-Purpose Disinfecting Solution (MPDS)
August 31, 2012 updated by: Alcon Research
A 30 Day, Multi-Centered, Open Label Study To Determine Comfort and Overall Contact Lens Wearing Experience Using OPTI-FREE RepleniSH® MPDS as Compared to COMPLETE®MPS Easy Rub™ or ReNu MultiPlus® in Daily Wear Soft Contact Lens Patients
The purpose of this study was to demonstrate that current successful fulltime daily wear soft contact lens wearers using competitive multi-purpose solutions will note improved comfort when using OPTI-FREE RepleniSH®.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
114
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Texas
-
Fort Worth, Texas, United States, 76134
- Alcon Call Center for Trial Locations
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Participants must be between 18 and 65 years of age.
- Must wear daily wear soft contact lenses a minimum of 8 hours per day,7 days a week.
- Must be wearing a planned replacement soft lens in a 2 week or monthly replacement modality.
- Must be using either COMPLETE Multi-Purpose Solution (MPS) Easy Rub or ReNu MultiPlus brand solution for at least 30 continuous days prior to enrollment.
- Must be free of any contact lens-related symptoms with regard to comfort and vision throughout their wearing hours prior to enrollment, with the exception of end-of-day dryness not limiting all day wear.
- Must have best corrected distance visual acuity, with contact lenses, of 20/30 or better in each eye.
- Must be willing to maintain pre-enrollment systemic medication regimens during the study.
- Must be willing to not use any topical medications or rewetting drops during the 30 day clinical trial duration.
- Other protocol-defined inclusion criteria may apply.
Exclusion Criteria:
- Has used any topical medication or rewetting drops for 7 days prior to enrollment.
- Achieves best visual correction by monovision.
- Has modified their systemic medications within 30 days prior to enrollment.
- Has switched brands of cosmetics during the 30 days prior to the study.
- Has a history of allergy to any study product ingredients.
- Is unwilling or unable to meet the study visit timeline.
- Has any active corneal, eyelid or other anterior segment inflammation or infection, which, in the opinion of the Investigator, would adversely affect successful contact lens wear.
- Other protocol-defined exclusion criteria may apply.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Opti-Free Replenish
Multi-purpose contact lens solution for cleaning and disinfecting study contact lenses used on a daily basis for 30 days.
|
OPTI-FREE RepleniSH® used according to product labeled instructions for cleaning and disinfecting study contact lenses, 30 days.
Other Names:
Contact lenses per participant's habitual prescription removed nightly for cleaning and disinfecting.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Comfort Ratings at Baseline
Time Frame: Baseline (Day 0)
|
Prior to any ocular assessments at the visit, comfort ratings were collected on a questionnaire using 5-point Likert scale, with 1=Strongly Agree, 1=Agree, 3=Neutral, 4=Disagree, 5=Strongly Disagree.
The percentage of participants responding with "Strongly Agree" or "Agree" for each question is presented.
|
Baseline (Day 0)
|
Comfort Ratings at 30 Days
Time Frame: 30 days
|
Prior to any ocular assessments at the visit, comfort ratings were collected on a questionnaire using 5-point Likert scale, with 1=Strongly Agree, 1=Agree, 3=Neutral, 4=Disagree, 5=Strongly Disagree.
The percentage of participants responding with "Strongly Agree" or "Agree" for each question is presented.
|
30 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2008
Primary Completion (Actual)
October 1, 2008
Study Completion (Actual)
October 1, 2008
Study Registration Dates
First Submitted
October 7, 2008
First Submitted That Met QC Criteria
October 13, 2008
First Posted (Estimate)
October 15, 2008
Study Record Updates
Last Update Posted (Estimate)
September 7, 2012
Last Update Submitted That Met QC Criteria
August 31, 2012
Last Verified
August 1, 2012
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- SMA-08-14
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Myopia
-
He Eye HospitalNot yet recruiting
-
University of BradfordCoopervision, Inc.; University of HuddersfieldNot yet recruiting
-
Visioneering Technologies, IncRecruitingMyopiaUnited States, Canada, Hong Kong, Singapore
-
University Eye Hospital, FreiburgRecruiting
-
Shanghai 10th People's HospitalCompletedMyopia | Myopia, ProgressiveChina
-
Tianjin Eye HospitalActive, not recruiting
-
Tianjin Eye HospitalCompleted
-
Sultan Qaboos UniversityChristian Medical College, Vellore, IndiaUnknown
-
Peking University People's HospitalUnknownProgressive MyopiaChina
-
Shanghai Eye Disease Prevention and Treatment CenterNot yet recruiting
Clinical Trials on Multi-Purpose Disinfecting Solution (OPTI-FREE RepleniSH)
-
Abbott Medical OpticsCompletedNormal Contact Lens WearersCanada
-
Alcon ResearchCompleted
-
Alcon ResearchCompletedContact LensesUnited Kingdom
-
Alcon ResearchCompleted
-
Alcon ResearchCompleted
-
Alcon ResearchCompletedRefractive ErrorsUnited States
-
Alcon ResearchCompletedRefractive ErrorsUnited States
-
Alcon ResearchCompletedRefractive Error | Astigmatism | MyopiaUnited States
-
Alcon ResearchCompletedSymptomatic Contact Lens WearersUnited States
-
Alcon ResearchCompletedMyopia | Contact Lens Fit